Delivery Order SPE2DB25D3202-SPE2DB25FTBEE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and is classified as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.06 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,641.17 for Mounjaro 7.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single shipment of this diabetes medication to support federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,131.67 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by August 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $10,834.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,631.78 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $1,565.12 delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen (0.5 mL), a diabetes medication, with an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing contract vehicle. The pharmaceutical will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,480.30 firm fixed-price contract is for the supply of Mounjaro 7.5 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has a period of performance through December 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,269.80 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded a $6,383.18 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen pharmaceutical supplies, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract contains no set-aside designation...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBEEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,793.15 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication used for glycemic control and weight management. This competitive, non-set-aside contract was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, under a firm fixed-price arrangement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This comprehensive pharmaceutical supply vehicle enables AmerisourceBergen to distribute a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen has established itself as a critical vendor within the Defense Logistics Agency's medical supply chain, consistently delivering competitively awarded contracts across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/19/25 |